These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31579410)

  • 1. The CK2 inhibitor CX4945 reverses cisplatin resistance in the A549/DDP human lung adenocarcinoma cell line.
    Jin C; Song P; Pang J
    Oncol Lett; 2019 Oct; 18(4):3845-3856. PubMed ID: 31579410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
    Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDIG promotes cisplatin resistance of lung adenocarcinoma by regulating ABC transporter expression via activation of the WNT/β-catenin signaling pathway.
    Wang Q; Geng F; Zhou H; Chen Y; Du J; Zhang X; Song D; Zhao H
    Oncol Lett; 2019 Oct; 18(4):4294-4307. PubMed ID: 31579066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of SOX4 on DDP Resistance in Non-small Cell Lung Cancer Cell of A549].
    Li W; Liu X; Zhang G; Zhang L
    Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):298-302. PubMed ID: 28532536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells.
    He J; Shi J; Zhang K; Xue J; Li J; Yang J; Chen J; Wei J; Ren H; Liu X
    Mol Med Rep; 2017 Apr; 15(4):1693-1701. PubMed ID: 28259951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-apoptotic brain and reproductive organ-expressed proteins enhance cisplatin resistance in lung cancer cells via the protein kinase B signaling pathway.
    Li Y; Qi K; Zu L; Wang M; Wang Y; Zhou Q
    Thorac Cancer; 2016 Mar; 7(2):190-8. PubMed ID: 27042221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
    Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
    Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect and mechanism of microRNA-21 on cis-dichlorodiamineplatinum resistance in lung cancer cell strain].
    Ren L; Huang C; Liu YH; Yu Y; Lin L; Wen LJ
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1454-8. PubMed ID: 27266356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
    Xie C; Pan Y; Hao F; Gao Y; Liu Z; Zhang X; Xie L; Jiang G; Li Q; Wang E
    APMIS; 2014 Dec; 122(12):1251-8. PubMed ID: 25131138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
    Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
    Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of disheveled-2 resensitizes cisplatin-resistant lung cancer cells through down-regulating Wnt/β-catenin signaling.
    Luo K; Gu X; Liu J; Zeng G; Peng L; Huang H; Jiang M; Yang P; Li M; Yang Y; Wang Y; Peng Q; Zhu L; Zhang K
    Exp Cell Res; 2016 Sep; 347(1):105-113. PubMed ID: 27432651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
    Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell].
    Jin Q; Zhu XH; Lin CZ; Zhang H; Cao YW; Ding XQ; Lyu ZH
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):252-257. PubMed ID: 29730910
    [No Abstract]   [Full Text] [Related]  

  • 15. Propofol Improves Sensitivity of Lung Cancer Cells to Cisplatin and Its Mechanism.
    Huang Y; Lei L; Liu Y
    Med Sci Monit; 2020 Mar; 26():e919786. PubMed ID: 32225124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Buzhong yiqi decoction containing serum reversed resistance of A549/DDP to cisplatin and its effect on the expression of survivin: an experimental research ].
    Yi JL; Wang Y; Jing H; Shi YT; Liu CY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1250-5. PubMed ID: 25509271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway.
    Chian S; Zhao Y; Xu M; Yu X; Ke X; Gao R; Yin L
    Anticancer Drugs; 2019 Sep; 30(8):838-845. PubMed ID: 31415285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
    Hu S; Hu CP; Liang CH
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hesperetin reverses P‑glycoprotein‑mediated cisplatin resistance in DDP‑resistant human lung cancer cells via modulation of the nuclear factor‑κB signaling pathway.
    Kong W; Ling X; Chen Y; Wu X; Zhao Z; Wang W; Wang S; Lai G; Yu Z
    Int J Mol Med; 2020 Apr; 45(4):1213-1224. PubMed ID: 32124932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
    Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J
    PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.